mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.8 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.8 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.8 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
AZD4547 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |